Cord Blood Registry Reports a Significant Increase in Number of
Children Needing Access to Their Own Cord Blood Stem Cells for
Treatment
Print article
Refer to a friend
© Business Wire 2008
2008-02-07 20:49:13 -
- Cord Blood Registry Laura Zobkiw Office: 650-635-1420 x1462 Cell:
650-544-6890 lzobkiw@cordblood.
dzitlow@cordblood.
and most experienced cord blood stem cell bank, announced today that
for the second year in a row, a record number of cord blood stem cell
collections stored at CBR have
been needed for medical use by the individual child from whom they
were collected (also called self-use or autologous use). In 2007, a
total of 16 cord blood collections stored at CBR were requested for
medical use, 11 of which (or 69%) were used for autologous infusion:
seven for children diagnosed with cerebral palsy, three for children
with juvenile diabetes and one with a rare immune system disorder.
Blood from the umbilical cord contains a diverse population of stem
cells that have shown an ability to differentiate into almost all of
the types of cells that comprise the human body. Cord blood stem
cells are increasingly being used in treatments for a wide range of
diseases and medical conditions to save and enhance lives.
The company also announced today that it anticipates this trend to
accelerate and reports that in the last 30 days, more than 30 current
clients have initiated the process for potential release of their
collection for medical use in 2008. Of these 30 cases, a total of
eight are in the process of being evaluated for infusion in the first
quarter. Six of these eight cases are for autologous use. A graph of
this data can be viewed at the following URL:
www.cordblood.
"CBR is increasingly playing an important and unique role in
connecting children whose cord blood stem cells we've processed and
stored, with physicians and medical researchers who are evaluating
the use of a child's own cord blood stem cells to treat conditions
that impact millions of Americans each year like juvenile diabetes,
cerebral palsy and brain injury," said Tom Moore, chief executive
officer of CBR. "We believe that autologous use of cord blood stem
cells will prove to be an important component in changing how these
conditions are managed in the future. Our role - and what
distinguishes us from public banks that make donated samples
available for public use - is that we guarantee every individual will
have access to his or her own cord blood stem cells so they can
benefit from autologous use in regenerative therapy if it is ever
needed."
A scientific analysis published last quarter in Current Stem Cell
Research & Therapy estimates that as many as 1 in 3 individuals in
the U.S. (or 128 million people) could benefit over their lifetime
from applications of regenerative medicine - the use of one's own
stem cells to repair or replace damaged or diseased tissue. Research
is also continuing to focus on cord blood as a preferred source of
stem cells, because they have demonstrated pluripotency -- the
ability to develop into almost all of the cell types in the body.
About Cord Blood Registry
Cord Blood Registry(R) (CBR(R)) is the world's largest cord blood
stem cell processing and cryopreservation service and offers families
guaranteed access to genetically-
for potential medical use. CBR was the first family bank accredited
by AABB and is the most recommended cord blood bank by obstetricians.
To date, CBR has processed and stored cord blood collections for more
than 200,000 newborns throughout the world and has released more than
65 client cord blood units for specific therapeutic use - more than
any other family cord blood bank. The company's research and
development efforts are focused on helping the world's leading
researchers advance regenerative medical therapies using cord blood
stem cells as well as continuing to introduce industry-leading
technical innovations for stem cell collection, processing and
storage that optimize quality and cell yield. Additionally, CBR
facilitates collection of donated samples, available for research
programs worldwide that are focused on stem cell expansion and other
cord blood stem cell-based therapies. For more information about CBR,
visit www.CordBlood.
Company Anticipates Trend to Accelerate in 2008
http://www.pr-
r427478.htm
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:
Children's Neurobiological Solutions
http://www.CNSfoundation.org/
Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123
The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch format to Traditional
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
__,_._,___
No comments:
Post a Comment